Regucalcin
Regucalcin (Japanese: レグカルシン), also known as Senescence Marker Protein-30 (SMP30), is a protein that in humans is encoded by the RGN gene. Regucalcin plays a crucial role in calcium signaling within cells, particularly in maintaining calcium homeostasis. It is widely expressed in various tissues, including the liver, kidney, heart, and brain, and has been implicated in a range of physiological and pathological processes.
Function[edit | edit source]
Regucalcin has a pivotal role in regulating intracellular calcium levels, which is vital for various cellular functions such as enzyme activities, gene expression, and cell proliferation. It acts by inhibiting the influx of calcium into cells and by modulating the activity of calcium pumps, which helps in reducing cytoplasmic calcium concentration. Additionally, regucalcin is involved in the suppression of apoptosis (programmed cell death), antioxidative responses, and the regulation of liver and kidney function.
Clinical Significance[edit | edit source]
The expression of regucalcin has been shown to decrease with age, linking it to age-related diseases. Its reduced levels have been associated with the pathogenesis of osteoporosis, due to its role in calcium homeostasis, and potentially with the development of certain types of cancer. Moreover, regucalcin plays a role in protecting cells against oxidative stress, suggesting its involvement in the prevention of diseases related to oxidative damage, such as cardiovascular diseases and neurodegenerative diseases.
Genetic Aspects[edit | edit source]
The RGN gene encoding regucalcin is located on chromosome 7 in humans. Variations in this gene may influence the expression or function of regucalcin, potentially affecting an individual's susceptibility to diseases related to calcium dysregulation.
Research Directions[edit | edit source]
Ongoing research is focused on elucidating the detailed mechanisms by which regucalcin regulates calcium homeostasis and its broader implications in health and disease. Studies are also exploring the potential of regucalcin as a therapeutic target for diseases associated with calcium imbalance and oxidative stress.
See Also[edit | edit source]
References[edit | edit source]
 | This medical article is a stub. You can help WikiMD by expanding it. |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
